This recognition is a testament to our relentless dedication to transforming healthcare through cutting-edge digital eye screening. From the very beginning, our mission has been clear: harness the power of technology to detect chronic diseases early and make preventive care more accessible to millions. Now, as we stand alongside the brightest innovators in Europe, we’re ready to elevate our impact to new heights.
The EIT Health Catapult is known for bringing together the most visionary start-ups in life sciences and healthtech, and being part of this community is a tremendous opportunity for CheckEye. It’s a chance to showcase our breakthrough solutions on an international stage and collaborate with leading experts shaping the future of health.
We are deeply grateful for this opportunity, and we look forward to taking bold steps towards realizing our full potential. Stay tuned as we continue this exciting journey towards improving global healthcare.
CheckEye has been chosen as a semi-finalist for the EIT Health Catapult 2024-25
